GlassScriptPhysician profile
Jenna M Monger
NPI 1528575560
$10,089.10
in general payments reported to CMS, 2019-2025
38 companies · $1,710 in 2025
The $1,710 reported for 2025 was more than what 93% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $2,153 · 2022: $1,988 · 2023: $2,332 · 2024: $1,906 · 2025: $1,710.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,935 · Education: $12.91.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,935.29 |
| Education | $12.91 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $1,258.50 | 2021-2024 | Xarelto |
| Novartis Pharmaceuticals Corporation | $1,226.78 | 2021-2025 | |
| Amgen INC. | $1,044.80 | 2021-2025 | Repatha, Repatha |
| Boehringer Ingelheim Pharmaceuticals, INC. | $958.12 | 2021-2025 | Jardiance |
| Pfizer INC. | $524.84 | 2021-2025 | |
| Daiichi Sankyo INC. | $388.51 | 2021-2023 | Injectafer |
| Novo Nordisk INC | $367.79 | 2023-2025 | Wegovy, Ozempic, Rybelsus |
| Amarin Pharma, INC. | $340.92 | 2021-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $333.75 | 2022-2025 | |
| Boston Scientific Corporation | $330.32 | 2023-2025 | Watchman Flx |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $324.79 | 2023-2025 | Lifevest |
| Sanofi-Aventis U.S. LLC | $295.43 | 2021-2024 | |
| Abbott Laboratories | $294.89 | 2021-2023 | Cardiomems |
| Actelion Pharmaceuticals US, INC. | $291.64 | 2021-2024 | Opsumit, Uptravi |
| Astrazeneca Pharmaceuticals LP | $254.39 | 2021-2025 | Andexxa, Farxiga |
Show all 38 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $229.14 | 2023-2025 | Camzyos, Eliquis |
| United Therapeutics Corporation | $222.65 | 2023-2025 | |
| Kestra Medical Technology Services, INC. | $205.63 | 2023-2025 | Assure Wcd |
| Irhythm Technologies, INC. | $158.58 | 2022-2024 | Zio Xt Patch, Zio Monitor |
| Alnylam Pharmaceuticals INC. | $151.39 | 2022-2025 | Amvuttra |
| Nevro Corp. | $142.19 | 2024 | Senza |
| Genzyme Corporation | $110.67 | 2022-2025 | |
| Regeneron Healthcare Solutions, INC. | $80.43 | 2024-2025 | Evkeeza |
| Merck Sharp & Dohme LLC | $72.53 | 2021-2024 | Verquvo |
| Csl Behring | $68.53 | 2021 | |
| Kowa Pharmaceuticals America, INC. | $63.95 | 2021-2022 | |
| Esperion Therapeutics, INC. | $61.52 | 2021-2024 | Nexletol |
| Kiniksa Pharmaceuticals International, Plc | $56.87 | 2024 | Arcalyst |
| Kiniksa Pharmaceuticals, LTD. | $47.85 | 2023 | Arcalyst |
| Atricure, INC. | $32.45 | 2023-2024 | |
| Azurity Pharmaceuticals, INC. | $30.69 | 2024-2025 | Edarbi |
| Arbor Pharmaceuticals, INC. | $27.04 | 2021 | |
| Lilly USA, LLC | $20.55 | 2025 | Zepbound |
| Medicomp INC | $18.02 | 2023 | Telepatch Cardiac Monitor |
| Glaxosmithkline, LLC. | $15.26 | 2025 | Arexvy |
| Baxter Healthcare | $14.56 | 2023 | Hillrom - Cardiac Ambulatory Monitor |
| Scpharmaceuticals INC. | $13.52 | 2025 | |
| Cvrx, INC. | $9.61 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jenna Monger listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.